American Portfolios Advisors’s Coherus Oncology CHRS Stock Holding History

American Portfolios Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$15.1K	Hold	1,576	–	–	﹤0.01%	2325
2022 Q2	$11.4K	Hold	1,576	–	–	﹤0.01%	2506
2022 Q1	$20.3K	Hold	1,576	–	–	﹤0.01%	2365
2021 Q4	$25.2K	Hold	1,576	–	–	﹤0.01%	2219
2021 Q3	$25.3K	Hold	1,576	–	–	﹤0.01%	2162
2021 Q2	$21.8K	Hold	1,576	–	–	﹤0.01%	2182
2021 Q1	$23K	Buy	+1,576	New	+$26.8K	﹤0.01%	1994
2018 Q2	–	Sell	-121	Closed	-$1.34K	–	2389
2018 Q1	$1.34K	Buy	+121	New	+$1.32K	﹤0.01%	2166

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

American Portfolios Advisors's CHRS Position: Q3 2022 in Review

American Portfolios Advisors held its Coherus Oncology (CHRS) position steady in Q3 2022 at 1,576 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

American Portfolios Advisors first reported a position in CHRS in Q1 2018 and has held it in 8 quarters since. The position peaked at $25.3K in Q3 2021. 174 funds tracked by Wall St. Rank hold CHRS as of Q3 2022.

American Portfolios Advisors held 1,576 shares of Coherus Oncology worth $15.1K as of Q3 2022.
American Portfolios Advisors left its Coherus Oncology share count unchanged in Q3 2022.
Coherus Oncology made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2325 holding.
American Portfolios Advisors first reported a position in Coherus Oncology in Q1 2018 and has held it in 8 quarters since.
American Portfolios Advisors's Coherus Oncology position peaked at $25.3K in Q3 2021.
174 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.